Forkhead box F2 as a novel prognostic biomarker and potential therapeutic target in human cancers prone to bone metastasis: a meta-analysis.
Qing ChenLei ZhouFancheng ChenAnnan HuKetao WangHaifeng LiangJian DongPublished in: The Journal of international medical research (2021)
These current findings indicate that high FOXF2 levels could be an indicator of a good prognosis in cancer patients with tumours that are prone to bone metastasis. FOXF2 levels might be a clinically important prognostic biomarker.